Literature DB >> 28799508

Editorial:Tubulin-targeted Cancer Chemotherapeutics: Advances and Challenges.

Manu Lopus1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28799508     DOI： 10.2174/156802661722170726113614

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN： 1568-0266            Impact factor:   3.295


× No keyword cloud information.
  3 in total

1.  Perturbation of tubulin structure by stellate gold nanoparticles retards MDA-MB-231 breast cancer cell viability.

Authors:  Jesuthankaraj Grace Nirmala; Ashish Beck; Sourabh Mehta; Manu Lopus
Journal:  J Biol Inorg Chem       Date:  2019-08-06       Impact factor: 3.358

Review 2.  Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials.

Authors:  Zhiyi Zhang; Jie Song; Cao Xie; Jun Pan; Weiyue Lu; Min Liu
Journal:  AAPS J       Date:  2021-02-12       Impact factor: 4.009

3.  Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols.

Authors:  Arvin M Gouw; Vineet Kumar; Angel Resendez; Fidelia B Alvina; Natalie S Liu; Katherine Margulis; Ling Tong; Richard N Zare; Sanjay V Malhotra; Dean W Felsher
Journal:  ACS Med Chem Lett       Date:  2022-03-30       Impact factor: 4.632
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.